Revisión sistemática y meta-análisis de ensayos randomizados | 02 DIC 13

Los implantes de colágeno con gentamicina en la reducción de la infección del sitio quirúrgico

Los autores de este trabajo realizaron una revisión sistemática y un meta-análisis de todos los ensayos clínicos randomizados, relacionados con las esponjas de colágeno impregnadas con gentamicina, para determinar si esos implantes de colágeno-gentamicina reducen la infección del sitio quirúrgico.
Autor/a: Dres. Chang WK, Srinivasa S, MacCormick AD, Hill A. Ann Surg 2013; 258(1): 59-65
INDICE:  1.  | 2. Referencias

1. Leaper DJ. Surgical site infection. Br J Surg. 2010;97:1601–1602.
2. Perencevich EN, Sands KE, Cosgrove SE, et al. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9:196–203.
3. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592.
4. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infection s in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–730.
5. Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–189.
6. Coello R, Glenister H, Fereres J, et al. The cost of infection in surgical patients: a case-control study. J Hosp Infect. 1993;25:239–250.
7. Fry DE. The economic costs of surgical site infection. Surg Infect. 2002;3(suppl 1):37–43.
8. Urban JA. Cost analysis of surgical site infections. Surg Infect. 2006;7(suppl 1):19–22.
9. Humphreys H. Preventing surgical site infection. Where now? J Hosp Infect. 2009;73:316–322.
10. Centers for Medicare & Medicaid Services. Quality measures for reporting in fiscal year 2009 and 2010 update. Available at:
11. Deficit Reduction Act 2005. Available at: . Accessed September 25, 2011.
12. Leaper D, Burman-Roy S, Palanca A, et al. Prevention and treatment of surgical site infection: summary of NICE guidance. BMJ. 2008;337:a1924.
13. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. Am J Infect Control. 1999;27:97–134.
14. Hanssen AD. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin Orthop Relat Res. 2005;437:91–96.
15. Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for the local delivery of antibiotics in bone infections. Drugs. 2000;59:1223–1232.
16. Kanellakopoulou K, Kolia M, Anastassiadis A, et al. Lactic acid polymers as biodegradable carriers of fluoroquinolones: an in vitro study. Antimicrob Agents Chemother. 1999;43:714–716.
17. Mehta S, Humphrey JS, Schenkman DI, et al. Gentamicin distribution from a collagen carrier. J Orthop Res. 1996;14:749–754.
18. Tsourvakas S, Hatzigrigoris P, Tsibinos A, et al. Pharmacokinetic study of fibrin clot-ciprofloxacin complex: an in vitro and in vivo experimental investigation. Arch Orthop Trauma Surg. 1995;114:295–297.
19. Noel SP, Courtney H, Bumgardner JD, et al. Chitosan films: a potential local drug delivery system for antibiotics. Clin Orthop Relat Res. 2008;466:1377–1382.
20. Friberg O, Svedjeholm R, Soderquist B, et al. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 2005;79:153–161.
21. Bennett-Guerrero E, Ferguson TB, Lin M, et al. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery. JAMA. 2010;304:755–762.
22. Bennett-Guerrero E, Pappas TN, Koltun WA, et al. Gentamicin–collagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med. 2010;363:1038–1049.
23. Schimmer C, Özkur M, Sinha B, et al. Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study. J Thorac Cardiovasc Surg. 2012;143:194–200.
24. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration. 2008. Available at: Accessed September 25, 2011
25. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341.
26. Current Controlled Trials. Available at: August 11, 2011.
27. Available at: Accessed August 11, 2011.
28. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
29. Gustafsson UM, Graf W. Randomized clinical trial of local gentamicin–collagen treatment in advancement flap repair for anal fistula. Br J Surg. 2006;93:1202–1207.
30. Holzer B, Grüssner U, Brückner B, et al. Efficacy and tolerance of a new gentamicin collagen fleece (Septocoll®) after surgical treatment of a pilonidal sinus. Colorectal Dis. 2003;5:222–227.
31. Collagen-gentamicin implant in the treatment of contaminated surgical abdominal wounds. Available at: August 11, 2011.
32. Local gentamicin application to reduce postoperative infection rate. Available at: Accessed August 11, 2011
33. Study using gentamicin sponge in surgical subjects at higher risk for wound infection. Available at: Accessed August 11, 2011.
34. Andersson RE, Lukas G, Skullman S, et al. Local administration of antibiotics by gentamicin–collagen sponge does not improve wound healing or reduce recurrence rate after pilonidal excision with primary suture: a prospective randomized controlled trial. World J Surg. 2010;34:3042–3048.
35. Buimer MG, Ankersmit MF, Wobbes T, et al. Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study. Dermatol Surg. 2008;34:224–227.
36. Eklund A, Valtonen M, Werkkala K. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. J Hosp Infect. 2005;59:108–112.
37. Gruessner U, Clemens M, Pahlplatz PV, et al. Improvement of perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after abdominoperineal excision of rectal cancer. Am J Surg. 2001;182:502–509.
38. Haase O, Raue W, Böhm B, et al. Subcutaneous gentamycin implant to reduce wound infections after loop-ileostomy closure: a randomized, double-blind, placebo-controlled trial. Dis Colon Rectum. 2005;48:2025–2031.
39. Mortensen J, Kraglund K, Klærke M, et al. Primary suture of anorectal abscess. Dis Colon Rectum. 1995;38:398–401.
40. Musella M, Guido A, Musella S. Collagen tampons as aminoglycoside carriers to reduce postoperative infection rate in prosthetic repair of groin hernias. Eur J Surg. 2001;167:130–132.
41. Rutten H, Nijhuis P. Prevention of wound infection in elective colorectal surgery by local application of a gentamicin-containing collagen sponge. Eur J Surg. 1997(suppl 578):31–35.
42. Vogel P, Lenz J. [Treatment of pilonidal sinus with excision and primary suture using a local, resorbable antibiotic carrier. Results of a prospective randomized study]. Chirurg. 1992;63:748–753.
43. Yetim I, Ozkan O, Dervisoglu A, et al. Effect of gentamicin-absorbed collagen in wound healing in pilonidal sinus surgery: a prospective randomized study. J Int Med Res. 2010;38:1029–1033.
44. Yetim I, Ozkan O, Dervisoglu A, et al. Effect of local gentamicin application on healing and wound infection in patients with modified radical mastectomy: a prospective randomized study. J Int Med Res. 2010;38:1442–1447.
45. Owens C, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008;70(suppl 2):3–10.
46. Karlowsky JA, Jones ME, Draghi DC, et al. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicrob. 2004;3:7.
47. Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev. 2003;55:1679–1698.
48. Friberg Ö, Jones I, Sjöberg L, et al. Antibiotic concentrations in serum and wound fluid after local gentamicin or intravenous dicloxacillin prophylaxis in cardiac surgery. Scand J Infect Dis. 2003;35:251–254.
49. Leyh RG, Bartels C, Sievers HH. Adjuvant treatment of deep sternal wound infection with collagenous gentamycin. Ann Thorac Surg. 1999;68:1648–1651.
50. Humphrey JS, Mehta S, Seaber AV, et al. Pharmacokinetics of a degradable drug delivery system in bone. Clin Orthop Relat Res. 1998;349:218–224.
51. Friberg Ö, Dahlin LG, Levin LÅ, et al. Cost effectiveness of local collagen-gentamicin as prophylaxis for sternal wound infections in different risk groups. Scand Cardiovasc J. 2006;40:117–125.
52. Wick EC, Hirose K, Shore AD, et al. Surgical site infections and cost in obese patients undergoing colorectal surgery. Arch Surg. 2011;146:1068–1072.
53. Fleischmann E, Lenhardt R, Kurz A, et al. Nitrous oxide and risk of surgical wound infection: a randomised trial. Lancet. 2005;366:1101–1107.
54. Serra-Aracil X, Garcia-Domingo MI, Pares D, et al. Surgical site infection in elective operations for colorectal cancer after the application of preventive measures. Arch Surg. 2011;146:606.
55. Chvapil M. Collagen sponge: theory and practice of medical applications. J Biomed Mater Res. 1977;11:721–741.
56. Ruszczak Z, Schwartz R. Collagen uses in dermatology—an update. Dermatology. 1999;199:285.
57. McHugh S, Collins C, Corrigan M, et al. The role of topical antibiotics used as prophylaxis in surgical site infection prevention. J Antimicrob Chemother. 2011;66:693.
58. Parvizi J, Saleh KJ, Ragland PS, et al. Efficacy of antibiotic-impregnated cement in total hip replacement. Acta Orthop. 2008;79:335–341.
59. Anglen JO. Comparison of soap and antibiotic solutions for irrigation of lower-limb open fracture wounds. A prospective, randomized study. J Bone Joint Surg Am. 2005;87:1415–1422.
60. Fleck T, Moidl R, Blacky A, et al. Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. Ann Thorac Surg. 2007;84:232–236.
61. Justinger C, Moussavian MR, Schlueter C, et al. Antibiotic coating of abdominal closure sutures and wound infection. Surgery. 2009;145:330–334.
62. Chang WK, Srinivasa S, Morton R, et al. Triclosan-impregnated sutures to decrease surgical site infections: systematic review and meta-analysis of randomized trials. Ann Surg. 2012;255:854–859.
63. Guller U. Surgical outcomes research based on administrative data: inferior or complementary to prospective randomized clinical trials? World J Surg. 2006;30:255–266.
64. McLeod RS. Issues in surgical randomized controlled trials. World J Surg. 1999;23:1210–1214.
65. Yamaguchi T, Ohashi Y, Matsuyama Y. Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials. Stat Methods Med Res. 2002;11:221–236 



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023